Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Centre Georges Francois Leclerc
With
INSERM U866 Faculté de Médecine et Pharmacie
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Women newly diagnosed with either:
Infiltrating non-metastatic breast cancer (positive or negative HER2 status or hormone therapy)
Breast cancer with a first metastasis evolution (positive or negative HER2 status or hormone therapy).
Ovarian cancer stage III and IV,
Men and women who are newly diagnosed non-small cell lung cancer metastatic,
Age ≥18 years
Affiliation to a social security system,
Signed Informed consent.
Men or women aged 50-70 years (mean age of onset of various cancers in the study)
Affiliation to a social security system,
Signed Informed consent.
You may not be if
Patient with another synchronous tumor,
Men with breast cancer,
Positive HIV and / or HBV and / or HCV serology
Patients unable to undergo a medical monitoring for geographical, social or psychological condition,
Pregnant or nursing women,
People enjoying a major protection system (including trusteeship and guardianship).
history of cancer,
Positive HIV and / or HBV and / or HCV serology
Pregnant or nursing women,
People enjoying a major protection system (including trusteeship and guardianship).
Clareo Health | Pilot Study With the Aim to Quantify a Stress Protein in the Blood and in the Urine for the Monitoring and Early Diagnosis of Malignant Solid Tumors
